| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Section of Infection and Immunity and
Department of Medical Biochemistry and Immunology, University of Wales, College of Medicine, Cardiff, United Kingdom;
Nestlé Research Center, Vers-Chez-Les-Blanc, Lausanne, Switzerland;
Division of Communicable Diseases, St. George’s Hospital Medical School, London, United Kingdom; and
¶ Sanofi-Synthelabo, Labège, France
Dysregulation of the initial, innate immune response to bacterial infection may lead to septic shock and death. Toll-like receptors (TLRs) play a crucial role in this innate immune response, and yet the regulatory mechanisms controlling microbial-induced TLR triggering are still to be fully understood. We have therefore sought specific regulatory mechanisms that may modulate TLR signaling. In this study, we tested for the possible existence of a functionally active soluble form of TLR2. We demonstrated the existence of natural soluble forms of TLR2 (sTLR2), which we show to be capable of modulating cell activation. We found that blood monocytes released sTLR2 constitutively and that the kinetics of sTLR2 release increased upon cell activation. Analysis of cells expressing the human TLR2 cDNA or its c-myc-tagged version indicated that sTLR2 resulted from the posttranslational modification of the TLR2 protein in an intracellular compartment. Moreover, an intracellular pool of sTLR2 is maintained. sTLR2 was found naturally expressed in breast milk and plasma. Milk sTLR2 levels mirrored those of the TLR coreceptor soluble CD14. Depletion of sTLR2 from serum resulted in an increased cellular response to bacterial lipopeptide. Notably, serum sTLR2 was lower in tuberculosis patients. Coimmunoprecipitation experiments and computational molecular docking studies showed an interaction between sTLR2 and soluble CD14 in plasma and milk. These findings suggest the existence of a novel and specific innate immune mechanism regulating microbial-induced TLR triggering, and may lead to new therapeutics for the prevention and/or treatment of severe infectious diseases.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  J. R. Conner, I. I. Smirnova, and A. Poltorak A mutation in Irak2c identifies IRAK-2 as a central component of the TLR regulatory network of wild-derived mice J. Exp. Med., July 6, 2009; 206(7): 1615 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gross, K. Brandl, C. Dierkes, J. Scholmerich, B. Salzberger, T. Gluck, and W. Falk Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria Infect. Immun., July 1, 2009; 77(7): 2925 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Raby, E. Le Bouder, C. Colmont, J. Davies, P. Richards, B. Coles, C. H. George, S. A. Jones, P. Brennan, N. Topley, et al. Soluble TLR2 Reduces Inflammation without Compromising Bacterial Clearance by Disrupting TLR2 Triggering J. Immunol., July 1, 2009; 183(1): 506 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Dulay, C. S. Buhimschi, G. Zhao, E. A. Oliver, A. Mbele, S. Jing, and I. A. Buhimschi Soluble TLR2 Is Present in Human Amniotic Fluid and Modulates the Intraamniotic Inflammatory Response to Infection J. Immunol., June 1, 2009; 182(11): 7244 - 7253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Frost and C. H. Lang Regulation of muscle growth by pathogen-associated molecules J Anim Sci, April 1, 2008; 86(14_suppl): E84 - E93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Torgler, S. E. Bongfen, J. C. Romero, A. Tardivel, M. Thome, and G. Corradin Sporozoite-Mediated Hepatocyte Wounding Limits Plasmodium Parasite Development via MyD88-Mediated NF-{kappa}B Activation and Inducible NO Synthase Expression J. Immunol., March 15, 2008; 180(6): 3990 - 3999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kalliomaki, M. Carmen Collado, S. Salminen, and E. Isolauri Early differences in fecal microbiota composition in children may predict overweight Am. J. Clinical Nutrition, March 1, 2008; 87(3): 534 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Conner, I. I. Smirnova, and A. Poltorak Forward genetic analysis of Toll-like receptor responses in wild-derived mice reveals a novel antiinflammatory role for IRAK1BP1 J. Exp. Med., February 18, 2008; 205(2): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Johnson and R. I. Tapping Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-{kappa}B-binding Site J. Biol. Chem., October 26, 2007; 282(43): 31197 - 31205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Whitmore, A. Iparraguirre, L. Kubelka, W. Weninger, T. Hai, and B. R. G. Williams Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3 J. Immunol., September 15, 2007; 179(6): 3622 - 3630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky, and C. L. Karp Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105 J. Leukoc. Biol., August 1, 2007; 82(2): 265 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Foster, S. R. Lea, P. M. Preshaw, and J. J. Taylor Pivotal Advance: Vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages J. Leukoc. Biol., April 1, 2007; 81(4): 893 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, P. E. Fegan, A. S. Desai, J. L. Madara, and M. E. Hobert Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G767 - G778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Perez, J. Dore, M. Leclerc, F. Levenez, J. Benyacoub, P. Serrant, I. Segura-Roggero, E. J. Schiffrin, and A. Donnet-Hughes Bacterial Imprinting of the Neonatal Immune System: Lessons From Maternal Cells? Pediatrics, March 1, 2007; 119(3): e724 - e732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mitsuzawa, C. Nishitani, N. Hyakushima, T. Shimizu, H. Sano, N. Matsushima, K. Fukase, and Y. Kuroki Recombinant Soluble Forms of Extracellular TLR4 Domain and MD-2 Inhibit Lipopolysaccharide Binding on Cell Surface and Dampen Lipopolysaccharide-Induced Pulmonary Inflammation in Mice J. Immunol., December 1, 2006; 177(11): 8133 - 8139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Pecora, A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function J. Immunol., July 1, 2006; 177(1): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Merrell, J. M. Ilvesaro, N. Lehtonen, T. Sorsa, B. Gehrs, E. Rosenthal, D. Chen, B. Shackley, K. W. Harris, and K. S. Selander Toll-Like Receptor 9 Agonists Promote Cellular Invasion by Increasing Matrix Metalloproteinase Activity Mol. Cancer Res., July 1, 2006; 4(7): 437 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. LeBouder, J. E. Rey-Nores, A.-C. Raby, M. Affolter, K. Vidal, C. A. Thornton, and M. O. Labeta Modulation of Neonatal Microbial Recognition: TLR-Mediated Innate Immune Responses Are Specifically and Differentially Modulated by Human Milk J. Immunol., March 15, 2006; 176(6): 3742 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seya, T. Akazawa, T. Tsujita, and M. Matsumoto Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 31 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brandl, T. Gluck, P. Hartmann, B. Salzberger, and W. Falk A designed TLR4/MD-2 complex to capture LPS Innate Immunity, August 1, 2005; 11(4): 197 - 206. [Abstract] [PDF]
|
|
|
|
 |
|
 J. C. Roach, G. Glusman, L. Rowen, A. Kaur, M. K. Purcell, K. D. Smith, L. E. Hood, and A. Aderem The evolution of vertebrate Toll-like receptors PNAS, July 5, 2005; 102(27): 9577 - 9582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fazeli, C. Bruce, and D.O. Anumba Characterization of Toll-like receptors in the female reproductive tract in humans Hum. Reprod., May 1, 2005; 20(5): 1372 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hyakushima, H. Mitsuzawa, C. Nishitani, H. Sano, K. Kuronuma, M. Konishi, T. Himi, K. Miyake, and Y. Kuroki Interaction of Soluble Form of Recombinant Extracellular TLR4 Domain with MD-2 Enables Lipopolysaccharide Binding and Attenuates TLR4-Mediated Signaling J. Immunol., December 1, 2004; 173(11): 6949 - 6954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. R. Weber, M. A. Morse, and N. J. Gay Four N-linked Glycosylation Sites in Human Toll-like Receptor 2 Cooperate to Direct Efficient Biosynthesis and Secretion J. Biol. Chem., August 13, 2004; 279(33): 34589 - 34594. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
